Predictors of persistent disease activity following anti-VEGF loading dose for nAMD patients in Singapore: the DIALS study.
Colin S H TanLouis W LimWei Kiong NgoPandiyan PannirselvamClarence SeeWai Kitt CheeNakul SaxenaPublished in: BMC ophthalmology (2020)
In a real-world study, 66.1% of nAMD patients have persistent disease activity after the initial loading dose, with poorer BCVA compared to those without. Baseline OCT features (intraretinal cysts and subretinal fluid) are useful predictors of persistent disease activity at month 3.